The complicated, evolving landscape of cancer mutations poses a formidable challenge to identify cancer genes among the large lists of mutations typically generated in NGS experiments. The ability to prioritize these variants is therefore of paramount importance. To address this issue we developed OncoScore, a text-mining tool that ranks genes according to their association with cancer, based on available biomedical literature. Receiver operating characteristic curve and the area under the curve (AUC) metrics on manually curated datasets confirmed the excellent discriminating capability of OncoScore (OncoScore cut-off threshold = 21.09; AUC = 90.3%, 95% CI: 88.1-92.5%), indicating that OncoScore provides useful results in cases where an efficient prioritization of cancer-associated genes is needed.
Piazza, R., Ramazzotti, D., Spinelli, R., Pirola, A., De Sano, L., Ferrari, P., et al. (2017). OncoScore: A novel, Internet-based tool to assess the oncogenic potential of genes. SCIENTIFIC REPORTS, 7 [10.1038/srep46290].
OncoScore: A novel, Internet-based tool to assess the oncogenic potential of genes
PIAZZA, ROCCO GIOVANNI
;RAMAZZOTTI, DANIELESecondo
;SPINELLI, ROBERTA;PIROLA, ALESSANDRA;MAGISTRONI, VERA;CORDANI, NICOLETTA;SHARMA, NITESH DEVINARAYANPenultimo
;GAMBACORTI PASSERINI, CARLOUltimo
2017
Abstract
The complicated, evolving landscape of cancer mutations poses a formidable challenge to identify cancer genes among the large lists of mutations typically generated in NGS experiments. The ability to prioritize these variants is therefore of paramount importance. To address this issue we developed OncoScore, a text-mining tool that ranks genes according to their association with cancer, based on available biomedical literature. Receiver operating characteristic curve and the area under the curve (AUC) metrics on manually curated datasets confirmed the excellent discriminating capability of OncoScore (OncoScore cut-off threshold = 21.09; AUC = 90.3%, 95% CI: 88.1-92.5%), indicating that OncoScore provides useful results in cases where an efficient prioritization of cancer-associated genes is needed.File | Dimensione | Formato | |
---|---|---|---|
OncoScore srep46290.pdf
accesso aperto
Dimensione
862.7 kB
Formato
Adobe PDF
|
862.7 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.